Third-party research requests
Supports independent investigator-initiated research and collaborations aligned with Regeneron's scientific and medical interests, ensuring compliance with ethical and regulatory standards.
Funder: Regeneron Pharmaceuticals
Due Dates: Rolling
Funding Amounts: Not specified; funding level and duration determined per project and proposal.
Summary: Supports independent investigators and clinicians in research initiatives aligned with Regeneron's scientific and medical interests, ensuring regulatory and ethical compliance.
Description
This mechanism provides support for independent investigators and clinicians seeking to conduct research projects or collaborations that align with Regeneron’s scientific and medical priorities. The program is designed to facilitate investigator-initiated studies and research partnerships, while maintaining strict compliance with legal, regulatory, and ethical standards. All activities must adhere to institutional requirements and industry codes, and any collaborative relationship with Regeneron must remain transparent and compliant.
